Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo

Published:2002-07-15 Issue:8 Volume:8 Page:808-815
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Fulda Simone,Wick Wolfgang,Weller Michael,Debatin Klaus-Michael

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm735.pdf

Reference45 articles.

1. Peto, J. Cancer epidemiology in the last century and the next decade. Nature 411, 390–395 (2001).

2. Ponder, B.A. Cancer genetics. Nature 411, 336–341 (2001).

3. Lowe, S.W. & Lin, A.W. Apoptosis in cancer. Carcinogenesis 21, 485–495 (2000).

4. Nicholson, D.W. From bench to clinic with apoptosis-based therapeutic agents. Nature 407, 810–816 (2000).

5. Hengartner, M.O. The biochemistry of apoptosis. Nature 407, 770–777 (2000).

Cited by 690 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanoparticle-mediated gene delivery of TRAIL to resistant cancer cells: A review;Heliyon;2024-08

2. Cancer cell-specific and pro-apoptotic SMAC peptide-doxorubicin conjugated prodrug encapsulated aposomes for synergistic cancer immunotherapy;Journal of Nanobiotechnology;2024-03-13

3. Clinically used drug arsenic trioxide targets XIAP and overcomes apoptosis resistance in an organoid-based preclinical cancer model;Chemical Science;2024

4. Overcoming the challenge: cell-penetrating peptides and membrane permeability;Biomaterials and Biosensors;2023-06-29

5. In Situ Self‐Assembly Supramolecular Antagonist Reinforces Radiotherapy by Inhibiting Tumor Apoptosis Evasion;Advanced Functional Materials;2023-05-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3